Table 1. Baseline characteristics of 76 patients and relatively primary tumor for HCC PDXs (N=76).

Characteristics	n/n
HCC, hepatocellular carcinoma; PDX, patient derived xenograft; IQR, interquartile range; macro-, macrovascular; micro-, microvascular.
Age (year) (median, IQR)	58.0, 52.3−66.0
Sex (male/female)	63/13
Specimen (primary/recurrent)	67/9
Prior treatment (not received/received)	64/12
Preoperative AFP level (ng/mL) (median, IQR)	39.1, 5.9−382.2
Liver cirrhosis (yes/no)	48/28
Tumor size (≤5 cm/>5 cm)	51/25
Tumor differentiation (well/moderate/poor)	3/43/30
Satellite lesions (yes/no)	63/13
Vascular invasion (macro-/micro-/no)	11/20/45